Clinical Trial Update: Comparison of Premixed Insulins Aspart 30, Aspart 70 and Aspart on Postprandial Lipids [Phase 4]

View source ↗

Summary

Phase 4 trial comparing premixed insulins Aspart 30, Aspart 70, and Aspart on postprandial lipids in Type 2 diabetes completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Insulin aspart (insulin aspart)
• premixed insulin aspart 30 (insulin aspart premixed 30%)
• premixed insulin aspart 70 (insulin aspart premixed 70%)

Snippet

Sponsor: Medical University of Graz | Conditions: Type 2 Diabetes | Phase 4 | Status: COMPLETED | Results posted: 2021-06-30